about
Early transcriptional alteration of histone deacetylases in a murine model of doxorubicin-induced cardiomyopathy.Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity.The paradox of the first cycle of chemotherapy-transient improvement of contractility and diastolic function after the first cycle of anthracycline-based chemotherapy: a prospective clinical trial.Translational opportunities for broad-spectrum natural phytochemicals and targeted agent combinations in breast cancer.Metformin enhances doxorubicin sensitivity via inhibition of doxorubicin efflux in P-gp-overexpressing MCF-7 cells.Editorial to: "Building a Bridge to the Future of Cardiovascular Drugs and Therapy".Low dose radiation prevents doxorubicin-induced cardiotoxicity.Severe mitral regurgitation, an unusual manifestation of chemotherapy-induced cardiotoxicity.Experimental evidence of good efficacy and reduced toxicity with peptide-doxorubicin to treat gastric cancer.Protective Mechanism of Hydrogen Sulfide against Chemotherapy-Induced Cardiotoxicity.Topoisomerases as anticancer targets.New insights into cardiotoxicity caused by chemotherapeutic agents.Cardiotoxicity of Anticancer Therapeutics.RFX1 participates in doxorubicin-induced hepatitis B virus reactivation.Plant-Derived Anticancer Agents: Lessons from the Pharmacology of Geniposide and Its Aglycone, Genipin.GCN2 deficiency ameliorates doxorubicin-induced cardiotoxicity by decreasing cardiomyocyte apoptosis and myocardial oxidative stress.Practical consensus recommendations regarding the management of HER2 neu positive early breast cancer.Synergistic Effect of Endogenous and Exogenous Aldehydes on Doxorubicin Toxicity in Yeast.Bioinformatics identification of potential candidate blood indicators for doxorubicin-induced heart failureNetwork and Pathway Analysis of Toxicogenomics DataNakai Has Synergetic Effects on Doxorubicin-Induced Apoptosis
P2860
Q33853732-285D1402-92D1-4E63-B441-43BE5F526AB5Q46253112-73490156-2C6E-4C2E-8076-BDB55ABB09DEQ47567559-20D2DABD-6EA7-422A-9366-A52B54C5A2DDQ47567895-F7655D94-2840-4134-ABD8-989F5D92927EQ47985167-182EC05D-6D61-4A3D-9CE3-027B64F94DADQ48059508-6F483CE7-2F03-4FC1-9B2D-5436EB9C310EQ49166221-D36A5E9B-A290-4E2D-8146-AC40EA36E790Q49313588-F5351B0D-70E9-4C24-BCBB-A658543A39A9Q49425807-4B54648E-4D50-4CD7-B7B5-D93135935C50Q49706717-5B7AFB23-1129-4C93-B190-BAA831B31668Q49832269-3931A329-5F88-4DF4-BA14-2864C7983B61Q50090528-D6B09FEB-9D1C-4C31-BABB-BAC9248A855CQ50326869-6F80D3CD-015E-407B-8FCA-3E1CC65E3716Q52618967-ACFF45C2-BB93-401D-A39D-C08844C0A6BBQ52723792-742296FD-26D5-40ED-BE28-8FA79D7F1C90Q54115847-4A457EDA-C299-4D76-B568-B51A75719DA5Q55080728-73A2B976-4857-49FA-8CC6-93D9C932E0DBQ55555497-F2855199-FDEC-4287-9F27-CF6F08D7F390Q57163637-09C58738-494A-4821-8766-65B6A7FA80F0Q58580378-EB36833F-E22A-40AF-A91A-E4B599B79165Q58805802-EE6B5403-5406-4282-B979-B6598F449F27
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Anthracycline Chemotherapy and Cardiotoxicity.
@en
Anthracycline Chemotherapy and Cardiotoxicity.
@nl
type
label
Anthracycline Chemotherapy and Cardiotoxicity.
@en
Anthracycline Chemotherapy and Cardiotoxicity.
@nl
prefLabel
Anthracycline Chemotherapy and Cardiotoxicity.
@en
Anthracycline Chemotherapy and Cardiotoxicity.
@nl
P2093
P2860
P921
P1476
Anthracycline Chemotherapy and Cardiotoxicity
@en
P2093
Angshuman Maulik
Izabela Piotrowska
John V McGowan
Robin Chung
P2860
P356
10.1007/S10557-016-6711-0
P577
2017-02-01T00:00:00Z